AGENUS INC — Director's Dealing 2017

Jan 30, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AGENUS INC (AGEN)
CIK: 0001098972
Period of Report: 2017-01-26

Reporting Person: Cuillerot Jean-Marie (Chief Medical Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option, Right to Buy	$4.3	2026-07-05	Common Stock (150000)		Direct
Restricted Stock Unit	$	2019-03-31	Common Stock (41250)		Direct

Footnotes

F1: Option awarded July 5, 2016 and vests in four equal annual installments beginning on the one-year anniversary of the grant date, subject to Dr. Cuillerot's continued employment with the Company.

F2: Represents the target amount of a Performance award that vests, if at all, in a single tranche on March 31, 2019 upon the achievement of share price goals (between $10 and $20 per share). Dr. Cuillerot can receive between 50% and 150% of the target amount based on the achievement of the share price goals.